These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 15242590

  • 1. Structural basis of BACH1 phosphopeptide recognition by BRCA1 tandem BRCT domains.
    Botuyan MV, Nominé Y, Yu X, Juranic N, Macura S, Chen J, Mer G.
    Structure; 2004 Jul; 12(7):1137-46. PubMed ID: 15242590
    [Abstract] [Full Text] [Related]

  • 2. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M, Yu X, Chen J, Songyang Z.
    J Biol Chem; 2003 Dec 26; 278(52):52914-8. PubMed ID: 14578343
    [Abstract] [Full Text] [Related]

  • 3. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN, Gu L, Yan N, Shi Y.
    Mol Cell; 2004 May 07; 14(3):405-12. PubMed ID: 15125843
    [Abstract] [Full Text] [Related]

  • 4. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
    Varma AK, Brown RS, Birrane G, Ladias JA.
    Biochemistry; 2005 Aug 23; 44(33):10941-6. PubMed ID: 16101277
    [Abstract] [Full Text] [Related]

  • 5. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA, Manke IA, Lowery DM, Ho T, Haire LF, Yaffe MB, Smerdon SJ.
    Nat Struct Mol Biol; 2004 Jun 23; 11(6):512-8. PubMed ID: 15133502
    [Abstract] [Full Text] [Related]

  • 6. The BRCT domain is a phospho-protein binding domain.
    Yu X, Chini CC, He M, Mer G, Chen J.
    Science; 2003 Oct 24; 302(5645):639-42. PubMed ID: 14576433
    [Abstract] [Full Text] [Related]

  • 7. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
    Lokesh GL, Rachamallu A, Kumar GD, Natarajan A.
    Anal Biochem; 2006 May 01; 352(1):135-41. PubMed ID: 16500609
    [Abstract] [Full Text] [Related]

  • 8. Kinetic analysis of interaction of BRCA1 tandem breast cancer c-terminal domains with phosphorylated peptides reveals two binding conformations.
    Nominé Y, Botuyan MV, Bajzer Z, Owen WG, Caride AJ, Wasielewski E, Mer G.
    Biochemistry; 2008 Sep 16; 47(37):9866-79. PubMed ID: 18717574
    [Abstract] [Full Text] [Related]

  • 9. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS, Lee MS, Hau DD, Glover JN.
    Nat Struct Mol Biol; 2004 Jun 16; 11(6):519-25. PubMed ID: 15133503
    [Abstract] [Full Text] [Related]

  • 10. BRCT repeats as phosphopeptide-binding modules involved in protein targeting.
    Manke IA, Lowery DM, Nguyen A, Yaffe MB.
    Science; 2003 Oct 24; 302(5645):636-9. PubMed ID: 14576432
    [Abstract] [Full Text] [Related]

  • 11. Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach.
    Tischkowitz M, Hamel N, Carvalho MA, Birrane G, Soni A, van Beers EH, Joosse SA, Wong N, Novak D, Quenneville LA, Grist SA, kConFab, Nederlof PM, Goldgar DE, Tavtigian SV, Monteiro AN, Ladias JA, Foulkes WD.
    Eur J Hum Genet; 2008 Jul 24; 16(7):820-32. PubMed ID: 18285836
    [Abstract] [Full Text] [Related]

  • 12. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
    Gough CA, Gojobori T, Imanishi T.
    Proteins; 2007 Jan 01; 66(1):69-86. PubMed ID: 17063491
    [Abstract] [Full Text] [Related]

  • 13. Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif.
    Wu Q, Jubb H, Blundell TL.
    Prog Biophys Mol Biol; 2015 Mar 01; 117(2-3):143-148. PubMed ID: 25701377
    [Abstract] [Full Text] [Related]

  • 14. The BRCA1-associated protein BACH1 is a DNA helicase targeted by clinically relevant inactivating mutations.
    Cantor S, Drapkin R, Zhang F, Lin Y, Han J, Pamidi S, Livingston DM.
    Proc Natl Acad Sci U S A; 2004 Feb 24; 101(8):2357-62. PubMed ID: 14983014
    [Abstract] [Full Text] [Related]

  • 15. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure.
    Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP.
    Genes Dev; 2002 Mar 01; 16(5):583-93. PubMed ID: 11877378
    [Abstract] [Full Text] [Related]

  • 16. Structural basis for the BRCA1 BRCT interaction with the proteins ATRIP and BAAT1.
    Liu X, Ladias JA.
    Biochemistry; 2013 Oct 29; 52(43):7618-27. PubMed ID: 24073851
    [Abstract] [Full Text] [Related]

  • 17. BRCA1-mediated repression of mutagenic end-joining of DNA double-strand breaks requires complex formation with BACH1.
    Dohrn L, Salles D, Siehler SY, Kaufmann J, Wiesmüller L.
    Biochem J; 2012 Feb 01; 441(3):919-26. PubMed ID: 22032289
    [Abstract] [Full Text] [Related]

  • 18. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
    Pustovalova Y, Maciejewski MW, Korzhnev DM.
    J Mol Biol; 2013 Sep 09; 425(17):3091-105. PubMed ID: 23747975
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.
    Leung CC, Gong Z, Chen J, Glover JN.
    J Biol Chem; 2011 Feb 11; 286(6):4292-301. PubMed ID: 21127055
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.